We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-29.17%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$186M
AUM Growth
+$106M
Cap. Flow
+$5.12M
Cap. Flow %
2.76%
Top 10 Hldgs %
78.1%
Holding
120
New
32
Increased
25
Reduced
31
Closed
26

Top Buys

Rank Stock Value
1
TEUM
Pareteum Corporation
TEUM
+$5.9M
2
HIND
Vyome Holdings
HIND
+$3.25M
3
CRMD icon
CorMedix
CRMD
+$2.09M
4
TRAW icon
Traws Pharma
TRAW
+$1.84M
5
XBIO icon
Xenetic Biosciences
XBIO
+$1.45M

Top Sells

Rank Stock Value
1
AMPE
Ampio Pharmaceuticals Inc.
AMPE
+$2.04M
2
SHIPW
Seanergy Maritime Holdings Corp Class A Warrants
SHIPW
+$1.54M
3
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$1.35M
4
BCLI
BRAINSTORM CELL THERAPUTC
BCLI
+$622K
5
CANF
Can-Fite BioPharma American Depositary Shares
CANF
+$610K

Sector Composition

Rank Sector Weight
1 Healthcare 14.92%
2 Technology 1.81%
3 Industrials 0.77%
4 Consumer Discretionary 0.32%
5 Real Estate 0.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCEL icon
101
FuelCell Energy
FCEL
$1.57B
– –
-588
Closed -$3K
PPBT
102
Purple Biotech
PPBT
$1.28M
– –
-7
Closed -$14K
QNRX
103
Quoin Pharmaceuticals
QNRX
$8.44M
– –
-2
Closed -$124K
RMTI icon
104
Rockwell Medical
RMTI
$27.6M
– –
-655
Closed -$217K
SINT icon
105
SiNtx Technologies
SINT
$9.92M
– –
0
– -$7K
SLS icon
106
SELLAS Life Sciences
SLS
$1.98B
– –
-78,520
Closed -$442K
STOK icon
107
Stoke Therapeutics
STOK
$1.83B
– –
-16,202
Closed -$473K
WVE icon
108
CALL
Wave Life Sciences
WVE
$1.13B
– –
-552
Closed -$1.44M
CSCI
109
PUT
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
– –
-5
Closed -$137K
OPGN
110
DELISTED
OpGen, Inc
OPGN
– –
-130
Closed -$204K
EMAN
111
DELISTED
eMagin Corporation
EMAN
– –
-861,903
Closed -$392K
AMPE
112
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
– –
-17,551
Closed -$2.04M
CALA
113
DELISTED
Calithera Biosciences, Inc
CALA
– –
-1,440
Closed -$112K
SGLBW
114
DELISTED
Sigma Labs, Inc. Warrant
SGLBW
– –
-65,033
Closed -$21K
SCON
115
DELISTED
Superconductor Technologies Inc.
SCON
– –
-46,790
Closed -$384K
AVEO
116
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
– –
-28,111
Closed -$209K
APDNW
117
DELISTED
Applied DNA Sciences Inc Warrant
APDNW
– –
-21,504
Closed -$86K
AKAO
118
DELISTED
Achaogen Inc
AKAO
– –
-134,192
Closed -$3K
SPHS
119
DELISTED
Sophiris Bio, Inc.
SPHS
– –
-52,685
Closed -$45K
SHIPW
120
DELISTED
Seanergy Maritime Holdings Corp Class A Warrants
SHIPW
– –
-965,000
Closed -$1.54M
1 2 3 4
5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q3 2019 Portfolio in Review

As of Q3 2019, Sabby Management held 120 positions worth $186M, up 133% from $79.5M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Sabby Management's Q3 2019 filing shows 32 new, 25 increased, 31 reduced and 26 closed positions. Its largest new stake was Pareteum Corporation: 2,248,578 shares worth $2.9M. The largest sale was Ampio Pharmaceuticals Inc., an estimated $2.04M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 37% a quarter earlier, followed by Technology and Industrials.

  • Sabby Management's largest Q3 2019 buy was Pareteum Corporation: 2,248,578 shares worth $2.9M.
  • Sabby Management added most to Advaxis Inc in Q3 2019, an estimated $1.01M increase.
  • Sabby Management's biggest Q3 2019 reduction was Odonate Therapeutics, Inc. Common Stock, cutting an estimated $1.35M.
  • Sabby Management fully exited Ampio Pharmaceuticals Inc. in Q3 2019, selling an estimated $2.04M.
  • Sabby Management's ten largest holdings make up 78% of its $186M portfolio in Q3 2019.
  • Sabby Management opened 32 new positions and closed 26 in Q3 2019.
  • Sabby Management's portfolio value rose 133% quarter-over-quarter to $186M.

Based on Sabby Management's 13F filing for Q3 2019, filed 15 Nov 2019.